Clinical Trials List
2021-06-01 - 2031-12-24
Phase III
Not yet recruiting2
Recruiting3
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 郭文宏 Division of General Surgery
- 蔡立威 Division of General Surgery
- 林柏翰 Division of General Internal Medicine
- 黃柏翔 Division of Hematology & Oncology
- MING-YANG WANG Division of General Surgery
- YEN-SHEN LU Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- SUNG-HSIN KUO Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 楊雅雯 Division of General Surgery
- 羅喬 Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Ta-Chung Chao Division of Hematology & Oncology
- Jiun-I Lai Division of Hematology & Oncology
- Yi-Fang Tsai Division of General Surgery
- Chun-Yu Liu Division of General Internal Medicine
- 馮晉榮 Division of General Surgery
- 林燕淑 Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- 邱仁輝 Division of General Surgery
- 賴亦貞 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Jung Chen Division of General Surgery
- Yao-Chung Wu Division of General Surgery
- Liang-Chih Liu Division of General Surgery
- 黃至豪 Division of General Surgery
- Chen-Teng Wu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Hung Chen Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Yao-Lung Kuo Division of General Surgery
- Jui-Hung Tsai Division of Hematology & Oncology
- 黃建璋 Division of General Surgery
- 楊舜如 Division of Hematology & Oncology
- Zhu-Jun Loh Division of General Surgery
- Wei-Pang Chung Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
1590 participants
